A phase 1 study of nevanimibe HCl, a novel adrenal-specific sterol O-acyltransferase 1 (SOAT1) inhibitor, in adrenocortical carcinoma

David C. Smith, Matthias Kroiss, Electron Kebebew, Mouhammed Amir Habra, Rashmi Chugh, Bryan J. Schneider, Martin Fassnacht, Pegah Jafarinasabian, M. Marian Ijzerman, Vivian H. Lin, Pharis Mohideen, Aung Naing

Research output: Contribution to journal › Article › peer-review

33 Scopus citations

Fingerprint

Dive into the research topics of 'A phase 1 study of nevanimibe HCl, a novel adrenal-specific sterol O-acyltransferase 1 (SOAT1) inhibitor, in adrenocortical carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences